News & Stories

Face ALS Symptoms: Identifying the Signs of ALS

Summary

At ALS United Ohio, we’re dedicated to supporting individuals and families affected by Amyotrophic Lateral Sclerosis (ALS) throughout our state. Our comprehensive approach combines care services, research support, and community engagement to enhance the quality of life for those living with ALS in Ohio. This article provides an in-depth look at ALS symptoms, diagnosis, and management strategies.

Understanding ALS: An Overview

Definition and characteristics of ALS

ALS is a progressive neurodegenerative disorder affecting motor neurons, leading to muscle weakness and eventual respiratory failure.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that affects both upper and lower motor neurons in the brain and spinal cord. This challenging condition leads to the gradual degeneration and death of motor neurons, resulting in muscle weakness, atrophy, and eventual paralysis[1].

ALS is characterized by its relentless progression, with symptoms typically beginning in one limb or region and spreading to other parts of the body over time. The hallmark feature of ALS is the coexistence of upper and lower motor neuron signs and symptoms, which distinguishes it from other motor neuron diseases[2].

Types of ALS: Bulbar-onset vs. Limb-onset

ALS can be classified into two main types based on the initial site of symptom onset: bulbar-onset and limb-onset ALS. Bulbar-onset ALS, affecting approximately one-third of patients, primarily impacts the muscles responsible for speech and swallowing. Initial symptoms often include speech difficulties, such as slurred speech or a hoarse voice, and trouble swallowing. This form of ALS is more commonly diagnosed in women and older individuals and tends to progress more rapidly than limb-onset ALS[4].

Limb-onset ALS, also known as spinal ALS, is the more prevalent form, affecting about two-thirds of patients. In this type, initial symptoms manifest in the arms, hands, legs, or feet. Early signs may include weakness in the dominant hand, difficulty with writing or holding objects, or balance issues and trouble walking when lower limbs are affected[5].

Prevalence and risk factors

Recent epidemiological studies have reported ALS incidence rates ranging from 0.6 to 3.8 per 100,000 person-years globally. European countries tend to have higher incidence rates, between 2.1 and 3.8 per 100,000 person-years, while Asian countries like South Korea and China report lower rates of 1.2 and 0.8 per 100,000 person-years, respectively[6].

Risk factors for ALS include older age, male sex, and family history. Recent analyses have suggested causal relationships between ALS and factors such as blood lipid levels, smoking, physical activity, and educational attainment. Occupational exposures to diesel exhaust, lead, and intense physical activity have also been associated with increased ALS risk[6].

Early Signs and Symptoms of ALS

Muscle weakness and fatigue

Muscle weakness and fatigue are hallmark symptoms of ALS, often appearing as early signs of the disease.

Muscle weakness and fatigue are hallmark symptoms of ALS, often appearing as early signs of the disease. In limb-onset ALS, which affects approximately 74% of patients, weakness typically begins in the arms or legs before progressing to other parts of the body[5].

This weakness may manifest as:

  • Difficulty gripping objects
  • Increased frequency of dropping items
  • Stumbling and falling more often

Tripping, dropping objects, and fine motor difficulties

As motor neurons deteriorate, individuals may experience increased clumsiness and coordination problems. Tripping becomes more frequent, especially on uneven surfaces or when navigating stairs, due to weakening leg muscles and reduced proprioception.

Dropping objects unexpectedly is another telltale sign, as hand strength and dexterity diminish. This symptom often manifests as difficulty gripping utensils, writing instruments, or performing tasks that require precise finger movements. Fine motor skills, such as buttoning shirts or tying shoelaces, become increasingly challenging as the disease progresses.

Speech changes and voice alterations

Speech changes and voice alterations are prominent symptoms in ALS, particularly in bulbar-onset cases where they often appear as early indicators. More than 80% of ALS patients experience dysarthria, characterized by difficulty articulating words and speaking clearly[10].

These speech problems can manifest in various ways, including:

  • A rough, strained, or hoarse voice
  • Breathy, quiet, or nasal speech
  • Slow, slurred speech that is challenging to understand

Face ALS Symptoms: Identifying the Signs

Facial muscle weakness and its manifestations

Facial muscle weakness is a prominent manifestation of ALS, particularly in bulbar-onset cases.

Facial muscle weakness is a prominent manifestation of ALS, particularly in bulbar-onset cases. As the disease progresses, patients may experience atrophy and weakness of muscles innervated by the lower brainstem, affecting the tongue, pharynx, larynx, jaw, and face[12].

This can lead to a constellation of symptoms, including:

  • Difficulty in articulation and swallowing
  • Atrophic, shriveled, and weak tongue with visible fasciculations
  • Impaired speech modulation resulting in defective articulation, variable degrees of rasping and nasality, and eventually unintelligible speech
  • Chewing and swallowing difficulties, potentially leading to choking episodes and fluid regurgitation through the nose

Changes in facial expressions and emotional display

Changes in facial expressions and emotional display are significant manifestations of ALS that can profoundly impact patients’ social interactions and quality of life. Studies have shown that ALS patients often exhibit deficits in recognizing facial emotions, particularly for expressions of disgust and surprise[13].

This impairment in emotion recognition is not limited to visual cues but extends to prosodic emotional recognition as well. Interestingly, some patients may show preserved simple facial affect recognition while struggling with more complex facial and prosodic emotion recognition tasks[14].

Drooling and difficulties with lip movements

Drooling and difficulties with lip movements are prominent symptoms in ALS, particularly in bulbar-onset cases. As the disease progresses, patients experience atrophy and weakness of muscles innervated by the lower brainstem, affecting the tongue, pharynx, larynx, jaw, and face[12].

Sialorrhea, or excessive drooling, affects about half of all ALS patients, with 20% experiencing moderate-to-severe symptoms. Contrary to common belief, sialorrhea in ALS is primarily caused by a decreased ability to swallow secretions rather than increased saliva production[15].

Advanced Diagnostic Techniques for ALS

Kinematic analysis of jaw and lip movements

Kinematic analysis of jaw and lip movements has emerged as a promising technique for early detection and monitoring of bulbar decline in ALS.

Kinematic analysis of jaw and lip movements has emerged as a promising technique for early detection and monitoring of bulbar decline in ALS. Studies have shown that facial kinematics can distinguish between presymptomatic and symptomatic phases of bulbar function decline with high accuracy (87%), relying solely on lip and jaw movements[16].

Key features for detecting early and later bulbar stages include:

  • Cumulative path of lower lip and jaw
  • Peak values of velocity, acceleration, and jerk of lower lip and jaw movements

Video-based facial movement assessment

Video-based facial movement assessment has emerged as a promising technique for evaluating bulbar ALS symptoms. Recent advancements in consumer-grade hardware and machine learning algorithms have made it possible to estimate facial movements from video recordings, offering a cost-effective and clinically applicable alternative to traditional kinematic methods[17].

A recent study utilizing a three-dimensional camera to record participants repeating a simple sentence demonstrated the effectiveness of this approach. By analyzing features related to sentence duration and facial movements, a machine learning model achieved an impressive 96.1% accuracy in distinguishing between healthy controls, early ALS, and late ALS groups[17].

Distinguishing presymptomatic and symptomatic phases

Distinguishing between presymptomatic and symptomatic phases of ALS is crucial for understanding disease progression and developing effective interventions. The presymptomatic phase can be further divided into pre-manifest and prodromal stages[18].

  1. Pre-manifest stage:
    • Characterized by the absence of clinical symptoms or signs
    • Disease detection relies solely on biomarker evidence
    • May reflect underlying molecular or cellular perturbations or successful compensation at a systems level
  2. Prodromal stage:
    • Begins with the emergence of possible or non-specific symptoms/signs
    • Precedes the definite manifestation of unequivocal disease
    • Subtle clinical symptoms or signs may be present, but insufficiently specific to confirm manifest disease

Comprehensive Management of ALS Symptoms

Multidisciplinary approach to ALS care

At ALS United Ohio, we champion a multidisciplinary care approach for managing ALS, integrating various healthcare disciplines to address complex and evolving needs.

At ALS United Ohio, we champion a multidisciplinary care (MDC) approach for managing ALS. This comprehensive model integrates various healthcare disciplines to address the complex and evolving needs of individuals with ALS. Our team typically involves specialists including:

  • Neurologists
  • Pulmonologists
  • Nutritionists
  • Speech therapists
  • Occupational therapists
  • Physical therapists
  • Palliative care specialists

Adaptive strategies for facial and bulbar symptoms

Managing facial and bulbar symptoms in ALS requires a multifaceted approach. At ALS United Ohio, we focus on enhancing communication, managing respiratory issues, and improving overall quality of life for individuals with ALS.

For speech difficulties, we recommend augmentative and alternative communication (AAC) devices, which can significantly improve an individual’s ability to express themselves. These electronic machines, coupled with voice output or head/eye tracking systems, have shown a stronger impact on quality of life compared to traditional speech therapy[20].

Supportive therapies and interventions

At ALS United Ohio, we offer a range of supportive therapies and interventions to help manage ALS symptoms and improve quality of life. Our approach encompasses:

  1. Respiratory support:
    • Noninvasive ventilation, such as bilevel positive airway pressure (BiPAP)
    • Various interfaces like masks or nasal inserts
    • Tracheostomy with invasive ventilation for severe cases[23]
  2. Speech therapy:
    • Voice banking techniques
    • Augmentative and alternative communication (AAC) devices[24]
  3. Nutritional support:
    • Dietary modifications
    • Feeding tube placement when swallowing becomes difficult or unsafe[24]

Conclusion

Living with ALS presents numerous challenges, but with the right support and resources, individuals can maintain a high quality of life. At ALS United Ohio, we’re committed to providing comprehensive care services, equipment support, and community engagement to help Ohioans affected by ALS navigate their journey.

Our dedicated team works tirelessly to enhance the lives of those living with ALS through our various programs and services. From our Medical Equipment Program to our support groups and educational resources, we’re here to support you every step of the way.

If you’d like to join us in our mission to support Ohioans affected by ALS, please consider making a donation. Your contribution can make a significant difference in the lives of individuals and families facing this challenging disease. Donate Now to help us continue providing essential services and support to our community.

Key Takeaways

  1. ALS is a progressive neurodegenerative disorder affecting motor neurons.
  2. Symptoms include muscle weakness, atrophy, and eventual respiratory failure.
  3. Diagnosis involves clinical examination, EMG, and exclusion of other conditions.
  4. Multidisciplinary care is crucial for managing ALS symptoms and improving quality of life.
  5. ALS United Ohio offers free support services, including equipment provision and caregiver resources.
References

  1. Mayo Clinic. (2021). Amyotrophic lateral sclerosis (ALS).
  2. Ghasemi, M. (2022). Amyotrophic Lateral Sclerosis. In StatPearls. StatPearls Publishing.
  3. ALS News Today. (2023). Forms of ALS.
  4. Medical News Today. (2023). Limb-onset ALS.
  5. Hardiman, O., et al. (2017). The changing picture of amyotrophic lateral sclerosis: lessons from European registers. Journal of Neurology, Neurosurgery & Psychiatry, 88(7), 557-563.
  6. ALS News Today. (2023). Speech Problems.
  7. Ghasemi, M. (2022). Amyotrophic Lateral Sclerosis. In StatPearls. StatPearls Publishing.
  8. Zimmerman, E. K., et al. (2007). Emotion perception deficits in amyotrophic lateral sclerosis. Neuropsychology, 21(6), 691-701.
  9. Bora, E. (2017). Meta-analysis of social cognition in amyotrophic lateral sclerosis. Cortex, 88, 1-7.
  10. Banfi, P., et al. (2019). Respiratory management of ALS patients with bulbar onset: a review. European Respiratory Review, 28(153), 190141.
  11. Yunusova, Y., et al. (2016). Profiling speech and pausing in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). PLoS One, 11(1), e0147573.
  12. Green, J. R., et al. (2022). Video-based estimation of facial movements for assessing bulbar ALS. IEEE Journal of Biomedical and Health Informatics, 27(1), 379-389.
  13. Benatar, M., et al. (2018). ALS biomarkers for therapy development: State of the field and future directions. Muscle & Nerve, 57(1), 20-30.
  14. Paganoni, S., et al. (2022). Comprehensive care of patients with amyotrophic lateral sclerosis. Nature Reviews Neurology, 18(2), 104-118.
  15. Mayo Clinic. (2023). Amyotrophic lateral sclerosis (ALS) – Diagnosis and treatment.
  16. Muscular Dystrophy Association. (2023). ALS Medical Management.

Share This Page: